Evidence for the Use of Biological Therapies in Ulcers of the Foot in Diabetes William J. JeffcoateFrances L. Game Current Opinion 06 July 2013 Pages: 1 - 6
Treg Vaccination in Autoimmune Type 1 Diabetes Isabelle SerrBenno WeigmannCarolin Daniel Leading Article 20 August 2013 Pages: 7 - 16
Second-Generation Tyrosine Kinase Inhibitors in First-Line Treatment of Chronic Myeloid Leukaemia (CML) Elisabetta AbruzzeseMassimo BrecciaRoberto Latagliata Review Article 17 September 2013 Pages: 17 - 26
Targeting Survivin in Cancer: Novel Drug Development Approaches Bernd GronerAstrid Weiss Review Article Open access 18 August 2013 Pages: 27 - 39
miR-125b Inhibitor May Enhance the Invasion-Prevention Activity of Temozolomide in Glioblastoma Stem Cells by Targeting PIAS3 Lei ShiYi WanYanjun Zeng Original Research Article 16 July 2013 Pages: 41 - 54
Pharmaceutical Costs of Desensitization Therapy in Patients Awaiting Lung Transplantation in France Annaë LiuMélisande Bernard Original Research Article 03 August 2013 Pages: 55 - 61
A Novel Double-Enhanced Suicide Gene Therapy in a Colon Cancer Cell Line Mediated by Gef and Apoptin Houria BoulaizAntonia AránegaPrados Jose Original Research Article 07 August 2013 Pages: 63 - 74
Intravenous Tocilizumab: A Review of Its Use in Adults with Rheumatoid Arthritis Sohita Dhillon Adis Drug Evaluation 20 November 2013 Pages: 75 - 106
Bosutinib: A Review of Its Use in Patients with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Yahiya Y. SyedPaul L. McCormackGreg L. Plosker Adis Drug Evaluation 14 January 2014 Pages: 107 - 120
Erratum to: A Novel Double-Enhanced Suicide Gene Therapy in a Colon Cancer Cell Line Mediated by Gef and Apoptin Houria BoulaizAntonia AránegaJose Prados Erratum 26 November 2013 Pages: 121 - 121
